Intended for healthcare professionals


Lung cancer trial has problems in recruitment

BMJ 2000; 321 doi: (Published 22 July 2000) Cite this as: BMJ 2000;321:195
  1. Susan Mayor
  1. London

    Nearly three quarters of patients eligible to take part in a UK trial of chemotherapy in non-small cell lung cancer have declined to take part, according to a study published last week that showed fear of side effects to be a major factor in patients' decisions.

    The big lung trial (BLT) aims to assess the effectiveness of chemotherapy in treating all stages of non-small cell lung cancer. Lead researcher Stephen Spiro, professor of respiratory medicine …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription